New dissolvable implant shows promise for smoothing wrinkles
NCT ID NCT07617350
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a medical device called ULTRACOL, a dissolvable implant placed under the skin, to see if it can safely improve wrinkles and other skin contour problems. 23 adults with facial wrinkles or skin aging took part. The main goal was to measure changes in wrinkle severity using a standard rating scale.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
23 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Apr 2025
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The subject has indications for use according to the manufacturer instructions for the device. * The subject is at least 18 years old at the time of signing the informed consent. * The subject expresses willingness and ability to follow the requirements of the study protocol. * The subject has no contraindications described in the device instructions for use. Exclusion Criteria: * The subject has at least one contraindication described in the device instructions for use, based on initial examination, laboratory tests and medical history. * Women of reproductive age: pregnancy, planning pregnancy during the study period, or breastfeeding. * Use of another product for the same indication during the clinical study. * Participation in another clinical study. * Pre-existing health problems that may compromise compliance with the study protocol. * Patients prone to excessive scarring. * Patients undergoing chemotherapy. * Patients previously treated with intradermal fillers in the planned injection zone with persistent effect.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Facial lipoatrophy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Estelab CLinic
Moscow, Russia, 119034, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rare fat disorder may quietly fuel hidden inflammation
- Can a new filler smooth smile lines as well as the leading one?
- Could a daily supplement recharge aging cells?
- A daily capsule might turn back the clock on skin and hair aging
- Could a mushroom compound turn back the clock on aging?
- Could a simple breakfast replace the glucose drink for diabetes testing?